Engineers Gate Manager’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Engineers Gate Manager’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-34,146	Closed	-$637K	–	2390
2022 Q1	$637K	Sell	34,146 -38,811	-53%	-$698K	0.02%	934
2021 Q4	$1.56M	Buy	72,957 +53,340	+272%	+$1.05M	0.07%	379
2021 Q3	$363K	Buy	+19,617	New	+$395K	0.02%	1080
2021 Q2	–	Sell	-130,606	Closed	-$2.52M	–	2186
2021 Q1	$2.52M	Buy	+130,606	New	+$2.3M	0.12%	189

Other funds holding OCDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Engineers Gate Manager's OCDX Position: Q2 2022 in Review

Engineers Gate Manager sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 34,146 shares — an estimated $637K sold.

Engineers Gate Manager first reported a position in OCDX in Q1 2021 and held it in 4 quarters. The position peaked at $2.52M in Q1 2021. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

Engineers Gate Manager reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
Engineers Gate Manager sold 34,146 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $637K.
Engineers Gate Manager first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2021 and held it in 4 quarters.
Engineers Gate Manager's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $2.52M in Q1 2021.
1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Engineers Gate Manager's 13F filing for Q2 2022, filed 15 Aug 2022.